Update Reimbursement Scheme Elvanse®
TBR Nederland hereby informs you that from now on the conditions regarding the Reimbursement Scheme Elvanse® 20 mg, 30 mg, 40 mg,...
Update Reimbursement Scheme Jardiance® 10mg - Chronic Kidney Disease
From February 1, 2024, the use of Jardiance® (empagliflozin) in adult patients with chronic kidney disease, with and without...
Reimbursement Scheme Kesimpta®
The health insurer does not fully reimburse Kesimpta® injvlst 50mg/ml pen 0,4ml. The producer of this medicine has therefore asked...
Update Reimbursement Scheme Forxiga® 10mg and Xigduo® 5mg
TBR Nederland hereby informs you that from now on the conditions regarding the Reimbursement Scheme Forxiga® 10mg and Xigduo® 5mg...
Reimbursement Scheme Adhesa®
The health insurer does not fully reimburse Adhesa® 5 mg. The producer of this medicine has therefore asked TBR Nederland to...
Select your medicine
Check your medicine expenses
Quickly check the maximum contribution you have to pay for your medicine